Symbol | Company | Weighting |
---|---|---|
GH | GUARDANT HEALTH INC | 3.05% |
ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 2.59% |
INSM | INSMED INC | 2.56% |
MRUS | MERUS NV | 2.41% |
MCK | MCKESSON CORP | 2.29% |
ABT | ABBOTT LABORATORIES | 2.22% |
AZN | ASTRAZENECA PLC-ADR | 2.21% |
PEN | PENUMBRA INC | 2.10% |
AXSM | AXSOME THERAPEUTICS INC. | 2.10% |
HCA | HCA HOLDINGS INC | 2.10% |
BSX | BOSTON SCIENTIFIC | 2.08% |
THC | TENET HEALTHCARE CORP | 2.07% |
DXCM | DEXCOM INC | 2.07% |
LLY | ELI LILLY CORP | 2.05% |
SMMT | SUMMIT THERAPEUTICS INC. | 2.01% |
AMLX | AMYLYX PHARMACEUTICALS INC | 2.00% |
SNY | SANOFI- AVENTIS- ADR | 1.98% |
ELV | ELEVANCE HEALTH INC | 1.94% |
ISRG | INTUITIVE SURGICAL INC | 1.92% |
NAMS | NEWAMSTERDAM PHARMA CO NV | 1.91% |
ALC | ALCON INC | 1.90% |
SYK | STRYKER CORP | 1.90% |
NBIX | NEUROCRINE BIOSCIENCES INC | 1.89% |
RMD | RESMED INC | 1.88% |
MOH | MOLINA HEALTHCARE INC | 1.88% |
ARGX | ARGENX SE ADR | 1.82% |
CI | THE CIGNA GROUP | 1.79% |
ZTS | ZOETIS INC | 1.76% |
BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.70% |
IDYA | IDEAYA BIOSCIENCES, INC | 1.64% |
NUVL | NUVALENT INC | 1.63% |
MRK | MERCK & CO. NEW | 1.60% |
GEHC | GE HEALTHCARE TECHNOLOGIES INC | 1.60% |
ARWR | ARROWHEAD PHARMACEUTICALS INC | 1.59% |
BIIB | BIOGEN INC | 1.56% |
TVTX | TRAVERE THERAPEUTICS INC | 1.54% |
RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.54% |
TMO | THERMO FISHER SCIENTIFIC INC | 1.51% |
ABVX | ABIVAX SA | 1.49% |
IMTX | IMMATICS NV | 1.49% |
HUM | HUMANA INC | 1.48% |
BDX | BECTON DICKINSON & CO | 1.41% |
NVO | NOVO NORDISK A/S | 1.41% |
CNTA | CENTESSA PHARMACEUTI | 1.40% |
ICLR | ICON PLC | 1.38% |
RVMD | REVOLUTION MEDICINES INC | 1.36% |
REGN | REGENERON PHARMACEUTICALS | 1.33% |
COO | COOPER COS INC | 1.32% |
TNDM | TANDEM DIABETES CARE INC | 1.31% |
CYTK | CYTOKINETICS INC | 1.30% |
GKOS | GLAUKOS CORPORATION | 1.29% |
INSP | INSPIRE MEDICAL SYSTEMS, INC. | 1.28% |
SNDX | SYNDAX PHARMACEUTICALS, INC. | 1.22% |
IMVT | IMMUNOVANT INC | 1.14% |
UNH | UNITEDHEALTH GROUP INC | 0.99% |
EWTX | EDGEWISE THERAPEUTICS | 0.91% |
PCVX | VAXCYTE INC | 0.76% |
GERN | GERON CORP | 0.72% |
ARVN | ARVINAS INC USD | 0.62% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.